Wichita Falls joins global city nature challenge movement
Taking place from April 25 to April 28, the event invites people of all ages and backgrounds to photograph and document the wildlife in their communities, contributing to one of the world's most significant community science efforts. Launched in 2016.
The challenge has grown from just 1,000 participants to a global movement involving hundreds of cities.
The Wichita Falls region, which includes Archer, Baylor, Clay, Foard, Jack, Hardeman, Montague, Wilbarger, and Young, is participating in its 5th year.
Lynn Seman, Master Naturalist, says the impact this challenge has had on the environment has been incredible.
'It helps us know what's out there and what should be out there and what should not be out there. Because, during the challenge, we also get observation of the invasive species. And in some in some ways, that's a good red flag to show us, hey, this is not supposed to be there,' Seman said.
Participants will use the free iNaturalist app and website to upload their footage and identify species.
'That app is a wonderful resource that is supported by a nonprofit. And they allow you to take photos of any living thing or any evidence of a living thing. So, not only can you take photos of plants insects, animals, birds, you can take pictures of animal tracks,' Seman said.
So, whether it's a flower in your front yard or a squirrel in the park, snap a photo and submit. You'll be joining a global effort to better understand the natural world.
For more information, head over to: City Nature Challenge
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hamilton Spectator
a day ago
- Hamilton Spectator
Bioblitz of Tagish uncovers important biodiversity data
More than 450 species never observed before in the Tagish area were reported during a bioblitz that the Yukon department of the environment ran on the weekend of July 19. 'Those species are probably, or almost certainly, not, new to the Tagish area in the sense that they just got there,' said Denny Bohmer, who is a coordinator for the Yukon Conservation Data Centre with the Yukon department of the environment. 'They've probably been there a long time, and we just didn't have the survey data or the observation data to know that they were in the Tagish area for sure, until we went out and did this bioblitz.' As Bohmer explained to the News on July 31, a bioblitz is an event where people — including members of the public — try to observe as many species as possible in a tight geographical area over the course of a few days. Bohmer helped to coordinate the bioblitz that took place around Tagish, including the Tagish campground and Tagish River. The reason bioblitzes are important, Bohmer said, is because they can help collect baseline data about where species are present. He said these events are especially useful in places like the Yukon, with vast geographical expanses and a small population. The Yukon Conservation Data Centre staged out the areas around Tagish and did some surveys on the Tagish River and the shoreline on July 19, Bohmer said. Then, July 20 saw several government employees dispersed among five sites in the Tagish area, including a wetland, salt flats, and subalpine forest. Members of the public were able to join the employees in these groups and capture data for the bioblitz using the iNaturalist app. The app will give a user an AI-generated guess of what species they're looking at or hearing, but other users on the app are also able to chime in, Bohmer said. These members of the public do not need to be experts, or even keen naturalists, to take part in a bioblitz Bohmer said. 'As long as they're out there and they're taking photos and uploading them to iNaturalist, they're still collecting useful data for the event,' he said. However, Bohmer said that the main purpose of getting members of the public to help out with bioblitzes is to help build an appreciation for the biodiversity of the Yukon. He said that July 21 saw a small, select group of local experts help with helicopter surveys of the area in more remote sites. The bioblitz was smaller than previous years, but Bohmer said that he still considered it to be a great success. There were 3,000 individual observations uploaded to iNaturalist over the course of those three days, representing more than 700 different species (including everything from fungi and lichens and mosses to animals and insects). Among those 700 species, there were a number of observations of species of conservation concern: species that may be rare or under threat in the Yukon or in Canada. This type of data can inform ecosystem description, which is another undertaking happening at the department of the environment, Bohmer said. He said that describing the ecosystems of the Yukon can help identify conservation areas, land use planning, as well as conservation planning for species. Knowing the range and distribution of a species is crucial to understanding its conservation status, or how rare a species is, Bohmer said. And there are more areas in the Yukon to understand, he said. The Ross River and Pelly River area is the highest priority for future bioblitzes, Bohmer said. He said it is an area with some species which are only found in the Yukon. 'It's been an area where we don't have a lot of baseline data, but we know there's a lot of rare and interesting species in the area, and a lot of the species experts who frequently come up to Yukon or live in Yukon have all consistently mentioned it as an exciting location.' Bohmer said he'd also like to run a little bioblitz around the Little Atlin Lake area, including the Tarfu and Snafu Lakes area. He's also been considering another bioblitz organized in the McIntyre Creek area, which is now part of the Chasàn Chùa territorial park. The McIntyre Creek area was subject of an early bioblitz: in 2015, the Yukon Conservation Society hosted that event, Bohmer said. Following that, the Yukon Conservation Data Centre has run bioblitzes in Carmacks, Watson Lake, Dawson, Beaver Creek, the Wildlife Preserve, and even a fly-in bioblitz at Ivvavik National Park. 'So we've had a fair amount of coverage, but there's still a lot of ground to cover, and lot of places that still are good candidates for future bioblitzes as well.' Bohmer said the results of this year's bioblitz should be made available at next year's biodiversity forum, once the species observed during the bioblitz can be confidently identified, a process which may include microscopes and analysis from species experts. The next bioblitz should take place next summer, Bohmer said. Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .
Business Wire
a day ago
- Business Wire
Exicure Completes the Last Patient, Last Visit in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed the last patient, last visit in its ongoing Phase 2 clinical trial (NCT05561751) evaluating the safety and efficacy of GPC-100 (burixafor) in combination with propranolol and G-CSF in multiple myeloma patients undergoing autologous stem cell transplant (ASCT). Topline results from the study are expected in the fourth quarter of 2025. The randomized, open-label, multicenter study is designed to assess whether GPC-100, a small molecule CXCR4 antagonist, can improve CD34+ hematopoietic stem cell mobilization from the bone marrow into the peripheral blood, where they can be collected via leukapheresis for use in ASCT. In data presented at ASH 2024, GPC-100 appears to be well differentiated in terms of the speed with which it mobilizes stem cells compared to currently approved stem cell mobilization treatments. Dr. Muthalagu Ramanathan, Director of the Myeloma Program and Medical Co-Director of the Blood and Marrow Transplant and CAR-T Program at U Mass Memorial Health noted that 'traditionally, patients undergoing mobilization are required to come, as an outpatient, the night before their procedure to receive the mobilization injection — a process that adds logistical challenges. The study drug GPC100 needed to be administered just 45 minutes before stem cell collection and resulted in a successful mobilization, significantly improving the patient experience. This is a true blessing for our frail myeloma patients.' In addition to multiple myeloma and a planned Phase 1 study in acute myeloid leukemia (AML) patients, the company is also in discussions for potential collaborations that would utilize GPC-100's rapid and safe mobilization of stem cells in cell and gene therapy settings. About GPC-100 GPC-100 (burixafor) is a highly selective small molecule antagonist of CXCR4, a chemokine receptor that plays a central role in retaining hematopoietic stem cells in the bone marrow niche. By blocking CXCR4, GPC-100 may enhance the mobilization of these cells into the peripheral blood for collection and use in autologous stem cell transplant (ASCT) procedures. Originally developed by GPCR Therapeutics, Inc., GPC-100 became part of Exicure's pipeline following the company's acquisition in January 2025. In addition to multiple myeloma, GPC-100 is also being considered in acute myeloid leukemia (AML) and other diseases where improved stem cell mobilization could help enable more efficient and effective treatment approaches, such as sickle cell disease, rare diseases requiring autologous transplant, and cell and gene therapy settings. About Exicure Exicure, Inc. (Nasdaq: XCUR) is a clinical-stage biotechnology company developing therapies to address key challenges in hematologic diseases. The company's lead program, GPC-100, is being evaluated for its ability to improve stem cell mobilization in multiple myeloma, sickle cell disease, and in support of cell and gene therapy. It is also being studied as a potential chemosensitizing agent in acute myeloid leukemia (AML). For more information, visit
Business Upturn
a day ago
- Business Upturn
Frequency Electronics Announces 2025 Quantum Sensing Summit in New York City
MITCHEL FIELD, N.Y., Aug. 01, 2025 (GLOBE NEWSWIRE) — Frequency Electronics, Inc. ('FEI' or the 'Company') (NASDAQ-FEIM), a leading provider of precision timing and frequency control products, today announced it will host the 2025 Quantum Sensing Summit on October 29–30, 2025, in New York City. The event will bring together leaders from government, industry, and research to accelerate the transition of quantum sensing technologies from the lab to mission-ready deployment. Building on the success of the inaugural 2024 summit, this year's two-day program will feature keynotes, panels, and technical sessions highlighting enabling technologies such as Rydberg and NV-diamond sensors, photonic integrated circuits (PICs), frequency combs, and ultra-low-noise oscillators. 'Quantum sensing is at the heart of the next technological revolution,' said Dr. Tom McClelland, CEO of Frequency Electronics. 'This summit is designed to forge the partnerships and strategies that turn today's breakthroughs into tomorrow's deployable solutions.' The summit is expected to attract 100–150 participants, including key government decision-makers, program managers, and industry innovators, providing a unique forum for collaboration and policy influence in the emerging quantum technology landscape. About Frequency Electronics Frequency Electronics, Inc. (FEI) is a world leader in the design, development and manufacture of high precision timing, frequency generation and RF control products for space and terrestrial applications. FEI's products are used in satellite payloads and in other commercial, government and military systems including C4ISR and electronic warfare, missiles, UAVs, aircraft, GPS, secure communications, energy exploration and wireline and wireless networks. FEI-Zyfer provides GPS and secure timing capabilities for critical military and commercial applications; FEI-Elcom Tech provides Electronic Warfare ('EW') sub-systems and state-of-the-art RF and microwave products. FEI has received over 100 awards of excellence for achievements in providing high performance electronic assemblies for over 150 space and DOD programs. The Company invests significant resources in research and development to expand its capabilities and markets. FEI's Mission Statement: 'Our mission is to transform discoveries and demonstrations made in research laboratories into practical, real-world products. We are proud of a legacy which has delivered precision time and frequency generation products, for space and other world-changing applications that are unavailable from any other source. We aim to continue that legacy while adapting our products and expertise to the needs of the future. With a relentless emphasis on excellence in everything we do, we aim, in these ways, to create value for our customers, employees, and stockholders.' Forward-Looking Statements The statements in this press release regarding future earnings and operations and other statements relating to the future constitute 'forward-looking' statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, our inability to integrate operations and personnel, actions by significant customers or competitors, general domestic and international economic conditions, reliance on key customers, continued acceptance of the Company's products in the marketplace, competitive factors, new products and technological changes, product prices and raw material costs, dependence upon third-party vendors, other supply chain related issues, increasing costs for materials, operating related expenses, competitive developments, changes in manufacturing and transportation costs, the availability of capital, the outcome of any litigation and arbitration proceedings, and failure to maintain an effective system of internal controls over financial reporting. The factors listed above are not exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in our filings with the Securities and Exchange Commission. The Company's Annual Report on Form 10-K for the fiscal year ended April 30, 2024, filed on August 2, 2024 with the Securities and Exchange Commission includes additional factors that could materially and adversely impact the Company's business, financial condition and results of operations, as such factors are updated from time to time in our periodic filings with the Securities and Exchange Commission, which are accessible on the Securities and Exchange Commission's website at Moreover, the Company operates in a very competitive and rapidly changing environment. New factors emerge from time to time and it is not possible for management to predict the impact of all these factors on the Company's business, financial condition or results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, investors should not rely on forward-looking statements as a prediction of actual results. Any or all of the forward-looking statements contained in this press release and any other public statement made by the Company or its management may turn out to be incorrect. The Company expressly disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Contact information: Dr. Thomas McClelland, President and Chief Executive Officer; Steven Bernstein, Chief Financial Officer; TELEPHONE: (516) 794-4500 ext.5000 WEBSITE: Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
